The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes and characteristics of patients receiving second-line therapy for advanced pancreatic cancer.
 
Erica S Tsang
No Relationships to Disclose
 
Hui-Li Wong
No Relationships to Disclose
 
Ying Wang
No Relationships to Disclose
 
Daniel John Renouf
Honoraria - Amgen; Celgene
Consulting or Advisory Role - Celgene; Shire
Research Funding - Bayer
 
Winson Y. Cheung
No Relationships to Disclose
 
Howard John Lim
Stock and Other Ownership Interests - Peregrine Pharmaceuticals
Honoraria - Ipsen; LEO Pharma; Lilly/ImClone; Merck; Roche Canada
 
Sharlene Gill
Honoraria - Celgene; Lilly
Consulting or Advisory Role - Celgene; Lilly; Shire; Taiho Pharmaceutical
Research Funding - Celgene
 
Jonathan M. Loree
No Relationships to Disclose
 
Hagen F. Kennecke
No Relationships to Disclose